title: National drug policies to local formulary decisions in Thailand, China, and Australia: drug listing changes and opportunities.
authors.affiliation: Bureau of Drug, Food and Drug Administration, Ministry of Public Health, Nonthaburi, Thailand. worasuda@fda.moph.go.th
authors.forename: Worasuda
authors.initials: W
authors.lastname: Yoongthong
authors.forename: Shanlian
authors.initials: S
authors.lastname: Hu
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Whitty
authors.forename: Suwit
authors.initials: S
authors.lastname: Wibulpolprasert
authors.forename: Kitti
authors.initials: K
authors.lastname: Sukantho
authors.forename: Wannisa
authors.initials: W
authors.lastname: Thienthawee
authors.forename: Huixue
authors.initials: H
authors.lastname: Han
authors.forename: Paul A
authors.initials: PA
authors.lastname: Scuffham
mesh_terms: D001315:Australia; D002681:China; D003657:Decision Making; D004363:Drug Utilization; D005569:Formularies as Topic; D006291:Health Policy; D006297:Health Services Accessibility / Q000458:organization & administration; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000191:economics*; D009313:National Health Programs / Q000191:economics / Q000458:organization & administration*; D011787:Quality of Health Care / Q000458:organization & administration; D013785:Thailand